ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "E118: The emerging risk of overdiagnosis in RA and PMR"
Episode Synopsis
Podcast this week about overdiagnosis! Currently one of my favorite topics and something that I think will be an emerging issue in our field. We recently published a Viewpoint in Lancet Rheumatology (https://pubmed.ncbi.nlm.nih.gov/39341221/) addressing this issue. I'm going to read from it and after that will be giving a few final (spicy) thoughts on the topic. Hope you find it worthwhile! s
More episodes of the podcast The Evidence Based Rheumatology Podcast
E130: Telitacicept for SLE
22/12/2025
E127: TNFs and All That CHF
22/09/2025
E126: Risk Signals, JAKs, and SELECTIVE-ity
08/09/2025
E122: Guidelines for Maybe Diagnosing HLH
17/04/2025
E121: Obinutuzumab in SLE-LN
02/04/2025
In God we trust